Search

everythinglearnresearchcommunity

for

Search:↓

Advanced male pattern baldness affects the back of the scalp, reducing hair follicles.

New dermoscopic criteria accurately diagnose and grade the severity of hair loss in androgenetic alopecia.

Trichoscopy helps tell apart other hair loss conditions from common hair loss.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

Higher homocysteine levels may inhibit hair growth and are linked to androgenetic alopecia.

Dutasteride is the most studied alternative drug for androgenetic alopecia, but more high-quality research is needed.

Laser-pretreated blood for hair loss treatment was more effective and increased stem cells.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

The study found that alopecia areata and hypothyroidism increase the risk of each other, but androgenetic alopecia and hypothyroidism do not.

Adipose-derived stem cells may help with hair loss, but more research is needed.

Adding the topical gel improved hair growth more than using minoxidil or finasteride alone.

Dutasteride injections can help hair growth in androgenic alopecia but need more research for long-term use.

Trichoscopy, a hair loss evaluation technique, found that people with Androgenetic Alopecia have more thin hairs, yellow dots, and perifollicular discoloration than healthy individuals.

Low-dose oral minoxidil effectively promotes hair growth but has associated risks.

The most effective way to diagnose non-scarring hair loss is by transverse sectioning, and some cases, particularly in males with inflammation around hair follicles, might be curable.

Hair loss is more common in male Chinese college freshmen, and it's linked with rosacea but doesn't affect their quality of life.

Probiotics help reduce hair loss and increase hair growth in people with androgenic alopecia.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Oral minoxidil is more convenient but topical minoxidil improves hair density better.

Polynucleotide gel injections help reduce hair loss and increase hair thickness in people with pattern hair loss, with few side effects.

Platelet-rich plasma therapy helps increase hair density in male patients with hair loss but doesn't change hair thickness.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

Nourkrin® with Marilex® may significantly increase hair growth and alopecia could be an early sign of metabolic syndrome.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

Androgenetic alopecia significantly affects mental health and quality of life, highlighting the need for psychiatric evaluations.

Hair density and thickness decrease in specific scalp areas in people with androgenetic alopecia.

The combined therapy significantly increased hair density and was safe for treating hair loss.

Using both platelet-rich plasma and minoxidil together gives the best results for hair growth in male rats with hair loss.